Caprolactam Chemicals Complete Financial Statements
In FYNone, Caprolactam Chemicals (CAPRO) reported revenue ₹9 Cr, net profit ₹1 Cr and EPS ₹1.00, with a net profit margin of -14.3% and ROE of -20.0%. Full financial statements from FY2015 to FY2025 (11 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Review CAPRO price earnings ratio to evaluate earnings-based valuation against sector peers.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
CAPRO Revenue, Net Profit & EBITDA — Year-on-Year Growth
CAPRO YoY (March 2025 vs Period) — revenue +28.6%, net profit +200.0%, EBITDA +50.0%, expenses +20.0%. Explore CAPRO Benjamin Graham valuation to estimate fundamental worth using multiple valuation models.
CAPRO Income Statement — Revenue, EBITDA & Net Profit
Caprolactam Chemicals revenue ₹9 Cr, EBITDA ₹3 Cr, net profit ₹1 Cr, EPS ₹1.00 (None) — net profit margin -14.3%. For live price, earnings ratios and company overview, see Caprolactam Chemicals stock price NSE.
| Particulars | None | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 9 | 7 | 7 | 10 | 3 | 6 | 7 | 5 | 4 | 3 | 5 | 3 |
| Expenses | 6 | 5 | 5 | 5 | 3 | 4 | 4 | 3 | 3 | 3 | 4 | 3 |
| EBITDA | 3 | 2 | 2 | 5 | 0 | 2 | 3 | 2 | 1 | 1 | 1 | 0 |
| Operating Profit Margin % | 32.00% | 23.00% | 31.00% | 48.00% | -27.00% | 34.00% | 39.00% | 36.00% | 22.00% | 14.00% | 17.00% | 13.00% |
| Depreciation | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| Interest | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 1 | -1 | 0 | 3 | -2 | 1 | 1 | 1 | 0 | 0 | 1 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 1 | -1 | 0 | 3 | -1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 |
| Earnings Per Share (₹) | 1.00 | -1.54 | 0.43 | 5.54 | -2.79 | 1.41 | 2.07 | 1.09 | 0.37 | -0.25 | 1.13 | -0.12 |
CAPRO Balance Sheet — Assets, Liabilities & Shareholders' Equity
CAPRO total assets ₹14 Cr, total equity ₹5 Cr, total liabilities ₹ Cr (2025) — ROE -20.0%.
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Total Assets | 14 | 12 | 12 | 10 | 7 | 7 | 7 | 6 | 4 | 4 | 3 |
| Current Assets | 4 | 1 | 1 | 1 | 2 | 1 | 1 | 2 | 1 | 1 | 0 |
| Fixed Assets | 10 | 10 | 10 | 5 | 6 | 6 | 6 | 4 | 3 | 3 | 3 |
| Capital Work in Progress | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 4 | 1 | 1 | 1 | 2 | 1 | 1 | 3 | 1 | 1 | 1 |
| LIABILITIES | |||||||||||
| Total Liabilities | |||||||||||
| Current Liabilities | 0 | 0 | 3 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | |||||||||||
| SHAREHOLDERS' EQUITY | |||||||||||
| Total Equity | 5 | 6 | 5 | 3 | 4 | 4 | 3 | 2 | 2 | 2 | 2 |
| Share Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves & Surplus | 0 | 1 | 1 | -2 | -1 | -1 | -2 | -3 | -3 | -3 | -3 |
CAPRO Cash Flow Statement — Operating, Investing & Financing
Caprolactam Chemicals operating cash flow ₹-1 Cr, investing ₹-2 Cr, financing ₹2 Cr, net cash flow ₹0 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -1 | 2 | 1 | 3 | 1 | 2 | 3 | 1 | 1 | 1 | 1 |
| Investing Activities | -2 | -2 | -2 | -5 | -1 | -1 | -4 | -1 | -1 | -1 | -2 |
| Financing Activities | 2 | 0 | 1 | 1 | -1 | -1 | 0 | 0 | 0 | 0 | 1 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 1 | 0 | 0 | 0 |